Kevin Fischbeck
Stock Analyst at B of A Securities
(4.09)
# 433
Out of 4,843 analysts
164
Total ratings
66.95%
Success rate
5.79%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| THC Tenet Healthcare | Maintains: Buy | $165 → $180 | $166.26 | +8.26% | 5 | May 14, 2025 | |
| UNH UnitedHealth Group | Downgrades: Neutral | $560 → $350 | $298.17 | +17.38% | 22 | May 14, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Buy | $50 → $45 | $22.85 | +94.75% | 6 | Feb 28, 2025 | |
| HCA HCA Healthcare | Maintains: Buy | $380 → $370 | $378.65 | -2.28% | 9 | Jan 27, 2025 | |
| HUM Humana | Upgrades: Neutral | $247 → $308 | $230.08 | +33.87% | 14 | Nov 6, 2024 | |
| ARDT Ardent Health Partners | Downgrades: Neutral | $22 → $19 | $14.70 | +29.25% | 2 | Nov 6, 2024 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $21.09 | +127.60% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $2.23 | +34.53% | 2 | Oct 2, 2024 | |
| DVA DaVita | Maintains: Underperform | $139 → $145 | $136.33 | +6.36% | 12 | Aug 7, 2024 | |
| ELV Elevance Health | Downgrades: Neutral | $646 → $530 | $380.53 | +39.28% | 3 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $303.87 | +44.47% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $8.97 | -27.54% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $14.90 | -51.33% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $79 → $72 | $56.52 | +27.39% | 11 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $312.05 | +12.16% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $183 | $191.05 | -4.21% | 14 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $22.83 | +97.15% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $120.01 | -38.34% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.90 | +41.03% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $15.17 | +130.72% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $3.13 | +219.49% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $13.31 | -43.65% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $32.26 | -44.20% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $14.23 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $28.40 | -33.10% | 2 | Feb 9, 2018 |
Tenet Healthcare
May 14, 2025
Maintains: Buy
Price Target: $165 → $180
Current: $166.26
Upside: +8.26%
UnitedHealth Group
May 14, 2025
Downgrades: Neutral
Price Target: $560 → $350
Current: $298.17
Upside: +17.38%
Acadia Healthcare Company
Feb 28, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $22.85
Upside: +94.75%
HCA Healthcare
Jan 27, 2025
Maintains: Buy
Price Target: $380 → $370
Current: $378.65
Upside: -2.28%
Humana
Nov 6, 2024
Upgrades: Neutral
Price Target: $247 → $308
Current: $230.08
Upside: +33.87%
Ardent Health Partners
Nov 6, 2024
Downgrades: Neutral
Price Target: $22 → $19
Current: $14.70
Upside: +29.25%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $21.09
Upside: +127.60%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $2.23
Upside: +34.53%
DaVita
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $136.33
Upside: +6.36%
Elevance Health
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $380.53
Upside: +39.28%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $303.87
Upside: +44.47%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $8.97
Upside: -27.54%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $14.90
Upside: -51.33%
Sep 5, 2023
Upgrades: Neutral
Price Target: $79 → $72
Current: $56.52
Upside: +27.39%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $312.05
Upside: +12.16%
Jul 27, 2023
Maintains: Buy
Price Target: $183
Current: $191.05
Upside: -4.21%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $22.83
Upside: +97.15%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $120.01
Upside: -38.34%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.90
Upside: +41.03%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $15.17
Upside: +130.72%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $3.13
Upside: +219.49%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $13.31
Upside: -43.65%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $32.26
Upside: -44.20%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $14.23
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $28.40
Upside: -33.10%